Gen Digital Inc (GEN) concluded trading on Wednesday at a closing price of $27.60, with 7.07 million shares of worth about $195.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.69% during that period and on May 21, 2025 the price saw a loss of about -2.85%. Currently the company’s common shares owned by public are about 617.00M shares, out of which, 561.51M shares are available for trading.
Stock saw a price change of -3.50% in past 5 days and over the past one month there was a price change of 13.86%. Year-to-date (YTD), GEN shares are showing a performance of 0.80% which increased to 10.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $22.74 but also hit the highest price of $31.72 during that period. The average intraday trading volume for Gen Digital Inc shares is 4.43 million. The stock is currently trading 1.36% above its 20-day simple moving average (SMA20), while that difference is up 4.43% for SMA50 and it goes to 1.09% higher than SMA200.
Gen Digital Inc (NASDAQ: GEN) currently have 617.00M outstanding shares and institutions hold larger chunk of about 86.62% of that.
The stock has a current market capitalization of $17.12B and its 3Y-monthly beta is at 0.99. PE ratio of stock for trailing 12 months is 26.79, while it has posted earnings per share of $1.03 in the same period. Its PEG reads 2.14 and has Quick Ratio of 0.51 while making debt-to-equity ratio of 3.66. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEN, volatility over the week remained 1.57% while standing at 2.44% over the month.
Stock’s fiscal year EPS is expected to rise by 12.71% while it is estimated to increase by 12.09% in next year. EPS is likely to grow at an annualized rate of 12.52% for next 5-years, compared to annual growth of 2.88% made by the stock over the past 5-years.
Coverage by UBS stated Gen Digital Inc (GEN) stock as a Buy in their note to investors on December 04, 2024, suggesting a price target of $36 for the stock. On October 24, 2024, Wells Fargo Initiated their recommendations, while on June 07, 2024, Morgan Stanley Downgrade their ratings for the stock with a price target of $27. Stock get an Equal weight rating from Barclays on April 11, 2024.
